A 64-week, multicenter, open-label study of aripiprazole effectiveness in the management of patients with schizophrenia or schizoaffective disorder in a general psychiatric outpatient setting.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples